Population-Based Validation of the MIA and MSKCC Tools for Predicting Sentinel Lymph Node Status.
Saved in:
| Title: | Population-Based Validation of the MIA and MSKCC Tools for Predicting Sentinel Lymph Node Status. |
|---|---|
| Authors: | Olofsson Bagge R; Sahlgrenska Center for Cancer Research, Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.; Wallenberg Centre for Molecular and Translational Medicine, University of Gothenburg, Gothenburg, Sweden.; Department of Surgery, Sahlgrenska University Hospital, Gothenburg, Sweden., Mikiver R; Regional Cancer Center Southeast Sweden and Department of Clinical and Experimental Medicine, Linköping University, Linköping, Sweden., Marchetti MA; Dermatology, Skagit Regional Health, Mt Vernon, Washington., Lo SN; Melanoma Institute Australia, The University of Sydney, Sydney, New South Wales, Australia.; Faculty of Medicine and Health, The University of Sydney, Sydney, New South Wales, Australia., van Akkooi ACJ; Melanoma Institute Australia, The University of Sydney, Sydney, New South Wales, Australia.; Faculty of Medicine and Health, The University of Sydney, Sydney, New South Wales, Australia., Coit DG; Gastric and Mixed Tumor Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York., Ingvar C; Department of Clinical Sciences, Surgery, Lund University, Lund, Sweden., Isaksson K; Department of Clinical Sciences, Surgery, Lund University, Lund, Sweden.; Department of Surgery, Kristianstad Hospital, Kristianstad, Sweden., Scolyer RA; Melanoma Institute Australia, The University of Sydney, Sydney, New South Wales, Australia.; Faculty of Medicine and Health, The University of Sydney, Sydney, New South Wales, Australia.; Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital and NSW Health Pathology, Sydney, New South Wales, Australia.; Charles Perkins Centre, The University of Sydney, Sydney, New South Wales, Australia., Thompson JF; Melanoma Institute Australia, The University of Sydney, Sydney, New South Wales, Australia.; Faculty of Medicine and Health, The University of Sydney, Sydney, New South Wales, Australia., Varey AHR; Melanoma Institute Australia, The University of Sydney, Sydney, New South Wales, Australia.; Faculty of Medicine and Health, The University of Sydney, Sydney, New South Wales, Australia.; Department of Plastic Surgery, Westmead Hospital, Sydney, New South Wales, Australia., Wong SL; Department of Surgery, Dartmouth-Hitchcock Medical Center, Lebanon, New Hampshire., Lyth J; Department of Health, Medicine and Caring Sciences, Linköping University, Linköping, Sweden., Bartlett EK; Gastric and Mixed Tumor Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York. |
| Source: | JAMA surgery [JAMA Surg] 2024 Mar 01; Vol. 159 (3), pp. 260-268. |
| Publication Type: | Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: American Medical Association Country of Publication: United States NLM ID: 101589553 Publication Model: Print Cited Medium: Internet ISSN: 2168-6262 (Electronic) Linking ISSN: 21686254 NLM ISO Abbreviation: JAMA Surg Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 2168-6262 |
|---|---|
| DOI: | 10.1001/jamasurg.2023.6904 |
